Vera Therapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 35.59, 261.11, 712.6, 995.01, 1361.46 ], "ebit_estimate": [ -467.99, -302.12, -4.13, 333.6, 643.56 ], "ebitda_estimate": [ -443.29, -249.32, 193.29, null, null ], "net_income_estimate": [ -455.14, -295.38, 12.64, 276, 551.59 ], "per_share_eps_estimate": [ -6.29, -3.92, -0.14, 4.16, 6.92 ], "eps_nri_estimate": [ -6.12, -3.69, 0.09, 3.99, 6.98 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 6.66, 3.18, null, null, null ], "pretax_income_estimate": [ -455.84, -297.36, 19.52, 362.96, 665.7 ], "operating_cash_flow_per_share_estimate": [ -5.66, -3.04, null, null, null ], "roa_estimate": [ -80.3, -64.6, null, null, null ], "roe_estimate": [ -90.2, -83.5, null, null, null ], "gross_margin_estimate": [ 75, 75, 76, 77, 77 ], "operating_cash_flow_estimate": [ -404.2, -216.93, null, null, null ], "pettm_estimate": [ 0, 0, 0, 10.09, 6.07 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 66.46, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 73.93, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, 7.06, 28.89, 46.52, 57.24, 74, 93.29 ], "ebit_estimate": [ -119.24, -117.91, -109.08, -88.89, -83.93, -73.7, -60.57 ], "ebitda_estimate": [ -118.55, -109.53, -90.38, -54.97, null, null, null ], "net_income_estimate": [ -115.5, -118.19, -110.73, -93.61, -81.08, -70.96, -58.35 ], "per_share_eps_estimate": [ -1.61, -1.61, -1.46, -1.17, -1, -0.83, -0.64 ], "eps_nri_estimate": [ -1.58, -1.52, -1.36, -1.12, -1.02, -0.85, -0.66 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -114.72, -118.71, -110.35, -93.61, -81.08, -70.96, -58.35 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, 75, 75, 75, 75, 75, 75 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 66.46, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 73.93, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }